×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Session 6 - Commercialization
Session Chair(s)
Steve Miller, MD
Senior Vice President & Chief Medical Officer
Express Scripts, United States
Speaker(s)
Cost of Investing in Biosimilar Development
Cecil J. Nick, MS
Parexel Consulting, United Kingdom
FTOPRA, Vice President (Technical)
Sustainability Studies
Steve Miller, MD
Express Scripts, United States
Senior Vice President & Chief Medical Officer
Investing Companies' View on Commercializing Biosimilars
Aharon Gal, PhD
Sanford C Bernstein, United States
Senior Research Analyst
Panel Discussion
All Session Speakers, United States
Have an account?